These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17633994)

  • 1. [Evaluation of radiofrequency (TUNA) in the outpatient treatment of benign prostatic hyperplasia].
    Fouques Y; Mallick S; Frachet O; Le Toquin S; Creveuil C; Bensadoun H
    Prog Urol; 2007 Jun; 17(4):824-7. PubMed ID: 17633994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is transurethral needle ablation of prostate out of fashion? Outcomes of single session office-based transurethral needle ablation of prostate in patients with symptomatic benign prostatic hyperplasia.
    Law YXT; Chen WJK; Shen L; Chua WJ
    Investig Clin Urol; 2019 Sep; 60(5):351-358. PubMed ID: 31501797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centers.
    Zlotta AR; Giannakopoulos X; Maehlum O; Ostrem T; Schulman CC
    Eur Urol; 2003 Jul; 44(1):89-93. PubMed ID: 12814680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of benign prostatic hyperplasia by radiofrequency (TUNA): a monocentric study of 28 cases treated in ambulatory surgery].
    Le Gal S; Fouques Y; Mallick S; Taksin L; Le Toquin-Bernard S; Frachet O; Bensadoun H
    Prog Urol; 2009 May; 19(5):327-32. PubMed ID: 19393538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical trial comparing transurethral needle ablation with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: results at 18 months.
    Cimentepe E; Unsal A; Saglam R
    J Endourol; 2003 Mar; 17(2):103-7. PubMed ID: 12689404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial.
    Hill B; Belville W; Bruskewitz R; Issa M; Perez-Marrero R; Roehrborn C; Terris M; Naslund M
    J Urol; 2004 Jun; 171(6 Pt 1):2336-40. PubMed ID: 15126816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of transurethral needle ablation of the prostate for symptomatic outlet obstruction.
    Rosario DJ; Woo H; Potts KL; Cutinha PE; Hastie KJ; Chapple CR
    Br J Urol; 1997 Oct; 80(4):579-86. PubMed ID: 9352697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feedback microwave thermotherapy with the ProstaLund Compact Device for obstructive benign prostatic hyperplasia: 12-month response rates and complications.
    Alivizatos G; Ferakis N; Mitropoulos D; Skolarikos A; Livadas K; Kastriotis I
    J Endourol; 2005; 19(1):72-8. PubMed ID: 15735388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of benign prostatic hyperplasia by Prostiva(®): about a series of 76 cases].
    Le Gal S; Le Toquin-Bernard S; Hurel S; Doerfler A; Salomon L; De La Taille A; Bensadoun H
    Prog Urol; 2011 Jun; 21(6):417-25. PubMed ID: 21620303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia: a collaborative multicentre study.
    Ramon J; Lynch TH; Eardley I; Ekman P; Frick J; Jungwirth A; Pillai M; Wiklund P; Goldwasser B; Fitzpatrick JM
    Br J Urol; 1997 Jul; 80(1):128-34; discussion 134-5. PubMed ID: 9240192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliot SP; Macdonald R; Wilt TJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004135. PubMed ID: 17943811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transurethral needle ablation of the prostate: a urodynamic based study with 2-year followup.
    Steele GS; Sleep DJ
    J Urol; 1997 Nov; 158(5):1834-8. PubMed ID: 9334612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do I treat and follow my TUNA patients.
    Barmoshe S; Zlotta AR
    World J Urol; 2006 Sep; 24(4):397-404. PubMed ID: 16858571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year results of transurethral resection of the prostate versus four 'less invasive' treatment options.
    Schatzl G; Madersbacher S; Djavan B; Lang T; Marberger M
    Eur Urol; 2000 Jun; 37(6):695-701. PubMed ID: 10828670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transurethral interstitial laser coagulation for benign prostatic hyperplasia: treatment outcome and quality of life.
    Arai Y; Ishitoya S; Okubo K; Suzuki Y
    Br J Urol; 1996 Jul; 78(1):93-8. PubMed ID: 8795408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary symptoms, quality of life and sexual function in patients with benign prostatic hypertrophy before and after prostatectomy: a prospective study.
    Gacci M; Bartoletti R; Figlioli S; Sarti E; Eisner B; Boddi V; Rizzo M
    BJU Int; 2003 Feb; 91(3):196-200. PubMed ID: 12581003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative randomized study on the efficaciousness of endoscopic bipolar prostate resection versus monopolar resection technique. 3 year follow-up.
    Giulianelli R; Albanesi L; Attisani F; Gentile BC; Vincenti G; Pisanti F; Shestani T; Mavilla L; Granata D; Schettini M
    Arch Ital Urol Androl; 2013 Jun; 85(2):86-91. PubMed ID: 23820656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bipolar and monopolar transurethral resection of the prostate on urinary and erectile function: a prospective randomized comparative study.
    Akman T; Binbay M; Tekinarslan E; Tepeler A; Akcay M; Ozgor F; Ugurlu M; Muslumanoglu A
    BJU Int; 2013 Jan; 111(1):129-36. PubMed ID: 22672229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations of transition zone volume and transition zone index after transurethral needle ablation for symptomatic benign prostatic hyperplasia.
    Fujimoto K; Hosokawa Y; Tomioka A; Yamamoto H; Tanaka Y; Otani T; Ozono S; Hirao Y; Hayashi Y
    Int J Urol; 2003 Jul; 10(7):392-7. PubMed ID: 12823695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of benign prostatic hyperplasia (BPH) by transurethral needle ablation (TUNA) and 36-month follow-up of the retreatment rate].
    Martin X; Claude A; Colombel M; Sarramon JP; Ballanger P; Lobel B; Richard F; Saussine C; Cavillon C; Buzelin JM; Baron JC; Lambert D; Haillot O
    Prog Urol; 2005 Sep; 15(4):674-80. PubMed ID: 16459684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.